Cited by 683Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and TherapyLysosomal Storage Disorders Research

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells

Open access

Vogiatzi, Tereza, Xilouri, Maria, Vekrellis, Kostas, Stefanis, Leonidas·2008·Journal of Biological Chemistry

DOI 10.1074/jbc.m801992200PMC PMC2527094

Open this paper in CoChat — free account Open PDF

Abstract

Alpha-synuclein (ASYN) is crucial in Parkinson disease (PD) pathogenesis. Increased levels of wild type (WT) ASYN expression are sufficient to cause PD in humans. The manner of post-transcriptional regulation of ASYN levels is controversial. Previously, we had shown that WT ASYN can be degraded by chaperone-mediated autophagy (CMA) in isolated liver lysosomes. Whether this occurs in a cellular and, in particular, in a neuronal cell context is unclear. Using a mutant ASYN form that lacks the CMA recognition motif and RNA interference against the rate-limiting step in the CMA pathway, Lamp2a, we show here that CMA is indeed involved in WT ASYN degradation in PC12 and SH-SY5Y cells, and in primary cortical and midbrain neurons. However, the extent of involvement varies between cell types, potentially because of differences in compensatory mechanisms. CMA inhibition leads to an accumulation of soluble high molecular weight and detergent-insoluble species of ASYN, suggesting that CMA dysfunction may play a role in the generation of such aberrant species in PD. ASYN and Lamp2a are developmentally regulated in parallel in cortical neuron cultures and in vivo in the central nervous system, and they physically interact as indicated by co-immunoprecipitation. In contrast to previous reports, inhibition of macroautophagy, but not the proteasome, also leads to WT ASYN accumulation, suggesting that this lysosomal pathway is also involved in normal ASYN turnover. These results indicate that CMA and macroautophagy are important pathways for WT ASYN degradation in neurons and underline the importance of CMA as degradation machinery in the nervous system.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.m801992200

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Autophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,559
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Self-citation
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference
Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J. E., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., et al. (2003) · Nature Genetics · doi:10.1038/ng1117 · Cited by 1,499

Show all 44 references

Research works printed but not linked: 1

Martinez-Vicente, 2008, J. Clin. Investig., 118, 777

Sorted by citations

Items 501–600 of 683

Secretory autophagy mediates lysosomal and autophagic degradation for α-synuclein proteostasis
Sawai, T., Nakamura, Y., & Arawaka, S. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110474 · Cited by 10
An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson’s Disease
Schechter, M., & Sharon, R. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212684 · Cited by 11
Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein
Kang, S., Kim, S., Noh, H. R., Kim, B. J., Kim, J.-B., Jin, U., Park, S. A., & Park, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158311 · Cited by 10
Autophagy at the synapse, an early site of dysfunction in neurodegeneration
Jasutkar, H. G., & Yamamoto, A. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100631 · Cited by 9
Adenosinergic Pathway in Parkinson’s Disease: Recent Advances and Therapeutic Perspective
Zhao, Y., Liu, X., & Yang, G. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03257-3 · Cited by 9
Development of small molecules for disrupting pathological amyloid aggregation in neurodegenerative diseases
Cao, T., Li, X., Li, D., & Tao, Y. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.25 · Cited by 10
Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis
Ali, A., Holman, A. P., Rodriguez, A., Osborne, L., & Kurouski, D. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106553 · Cited by 10
Overview of Autophagy
Hayat, M. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812146-7.00001-9 · Cited by 10
Investigation of the novel mTOR inhibitor AZD2014 in neuronal ischemia
Hadley, G., Beard, D. J., Alexopoulou, Z., Sutherland, B. A., & Buchan, A. M. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.05.023 · Cited by 9
Drosophila as a model to study autophagy in neurodegenerative diseases and digestive tract
Tzou, F., Wen, J., Yeh, J., Huang, S., Chen, G., & Chan, C. (2021) · IUBMB Life · doi:10.1002/iub.2583 · Cited by 9
Novel Molecular Targets and Mechanisms for Neuroprotective Modulation in Neurodegenerative Disorders
Irannejad, H., Azari, A., Goodarzi, A., Jafarkhani, B., Eghbali, M., Karimi, Z., & Balef, S. S. H. (2022) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524922666220616092132 · Cited by 8
α-Synuclein Degradation in Brain Pericytes Is Mediated via Akt, ERK, and p38 MAPK Signaling Pathways
Yokoya, M., Takata, F., Iwao, T., Matsumoto, J., Tanaka, Y., Aridome, H., Yasunaga, M., Mizoguchi, J., Sano, K., & Dohgu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041615 · Cited by 10
Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration
Huo, Y., Sawant, A., Tan, Y., Mahdi, A., Li, T., Ma, H., Bhatt, V. D., Yan, R., Coleman, J., Dreyfus, C. F., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010138 · Cited by 8
Autophagy enhancement is rendered ineffective in presence of α-synuclein in melanoma cells
Nandakumar, S., Vijayan, B., Kishore, A., & Thekkuveettil, A. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0402-x · Cited by 9
Targeted disruption of neuronal 19S proteasome subunits induces the formation of ubiquitinated inclusions in the absence of cell death
Droggiti, A., Ho, C. C., Stefanis, L., Dauer, W. T., & Rideout, H. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07444.x · Cited by 8
Self-citation
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 8
A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy
Pupyshev, A. B., Короленко, Т. А., & Tikhonova, M. A. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0519-7 · Cited by 8
Rab27b Promotes Lysosomal Function and Alpha-Synuclein Clearance in Neurons
Scholz, K., Pattanayak, R., Ekkatine, R., Pair, F. S., Nobles, A. C., Stone, W. J., & Yacoubian, T. A. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1579-24.2025 · Cited by 7
Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models
Pozo, S. L. D., Uras, G., Fierli, F., Lentini, V., Koletsi, S., Lazaro-Hernandez, C., Chau, K., Hughes, D. A., & Schapira, A. H. V. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107053 · Cited by 7
Chronic exposure to cerebrospinal fluid of multiple system atrophy in neuroblastoma and glioblastoma cells induces cytotoxicity via ER stress and autophagy activation
Wang, X., Ma, M., Teng, J., Zhang, J., Zhou, S. Y., Zhang, Y., Wu, E., & Ding, X. (2015) · Oncotarget · doi:10.18632/oncotarget.3748 · Cited by 7
α-synuclein buildup is alleviated via ESCRT-dependent endosomal degradation brought about by p38MAPK inhibition in cells expressing p25α
Madsen, H. B., Rasmussen, I., Bjerregaard-Andersen, K., Rasmussen, M., Olsen, A., & Vilhardt, F. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102531 · Cited by 7
The Hsp70 Chaperone System in Parkinson’s Disease
Labrador‐Garrido, A., Carlos, W., & Roodveldt, C. (2011) · InTech eBooks · doi:10.5772/16671 · Cited by 7
Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells
Vo, M., Choi, S. H., Lee, J.-H., Hong, C. H., Kim, J. S., Lee, U. H., Chung, H., Lee, B. J., Park, J. W., & Cho, W. J. (2017) · Oncotarget · doi:10.18632/oncotarget.16706 · Cited by 7
Absence of Rab39b-induced macroautophagy impairment increases neurotoxic α-synuclein and causes degeneration of substantia nigra dopaminergic neurons in mouse model of X-linked Parkinson's disease
Chiu, C., Weng, Y.-H., Yeh, T., Chen, W.-S., Liu, S.-Y., Chiu, T.-J., Li, A. H.-L., & Wang, H. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123789 · Cited by 6
A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches
Siddique, Y. H., & Owais, S. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220111152756 · Cited by 6
Accumulation of alpha-synuclein pathology in the liver exhibits post-translational modifications associated with Parkinson’s disease
Hallbeck, M., Ekmark‐Lewén, S., Kahle, P. J., Ingelsson, M., & Reyes, J. F. (2024) · iScience · doi:10.1016/j.isci.2024.111448 · Cited by 6
USP10 inhibits the degradation of α-synuclein, a pathogenic factor associated with Parkinson's disease, by inhibiting chaperone-mediated autophagy
Anisimov, S., Takahashi, M., Kakihana, T., Katsuragi, Y., Sango, J., Abe, T., & Fujii, M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110292 · Cited by 6
Physiology of cellular demise: Apoptosis, necrosis, and autophagy
Kaur, D., & Deshmukh, R. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815762-6.00002-0 · Cited by 10
Opportunities for Cellular Rejuvenation in Alzheimer's Disease: How Epigenetic Reprogramming and Chaperone-Mediated Autophagy Are Enabling Next Generation Therapeutic Approaches
Rosenzweig-Lipson, S. J. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.106 · Cited by 6
Pathways of protein synthesis and degradation in PD pathogenesis
Langston, R. G., & Cookson, M. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.01.002 · Cited by 7
An update on cellular and molecular determinants of Parkinson's disease with emphasis on the role of the retromer complex
Macías‐Calvio, V., Fuentealba, L., & Marzolo, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24675 · Cited by 7
Intersection of Redox Chemistry and Ubiquitylation: Post-Translational Modifications Required for Maintaining Cellular Homeostasis and Neuroprotection
Kane, E. I., Waters, K. L., & Spratt, D. E. (2021) · Cells · doi:10.3390/cells10082121 · Cited by 6
Inhibition of α-Synuclein Aggregation by Antioxidants and Chaperones in Parkinson’s Disease
Rochet, J., & Liu, F. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_8 · Cited by 7
Impaired $$\alpha$$-Synuclein aggregate clearance in neuronal cells drive their spread to microglia through tunneling nanotubes
Chakraborty, R., Palese, F., Samella, P., Testa, V., Montero-Muñoz, J., Syan, S., Nonaka, T., Hasegawa, M., Consiglio, A., & Zurzolo, C. (2026) · Nature Communications · doi:10.1038/s41467-026-69930-y · Cited by 11
Nonintuitive Immunogenicity and Plasticity of Alpha-Synuclein Conformers: A Paradigm for Smart Delivery of Neuro-Immunotherapeutics
Abioye, A. O., Akintade, D. D., Mitchell, J., Olorode, S., & Adejare, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050609 · Cited by 7
Astrocytes initiate autophagic flux and maintain cell viability after internalizing non-active native extracellular α-synuclein
Andromidas, F., MacKinnon, B., Myers, A. J., Shaffer, M. M., Brahimi, A., Atashpanjeh, S., Vazquez, T. L., Le, T., Jellison, E. R., Staurovsky, S., et al. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103975 · Cited by 4
The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation
Fujimori, H., Ohba, T., Nakamura, S., Shimazawa, M., & Hara, H. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00711 · Cited by 5
The influence of zwitterionic and anionic phospholipids on protein aggregation
Ali, A., Dou, T., Holman, A. P., Hung, A., Osborne, L., Pickett, D. N., Rodriguez, A., Zhaliazka, K., & Kurouski, D. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107174 · Cited by 5
Reduction of WDR81 impairs autophagic clearance of aggregated proteins and cell viability in neurodegenerative phenotypes
Liu, X., Yin, L., Li, T., Lin, L., Zhang, J., & Li, Y. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009415 · Cited by 6
Retracted
DJ-1 as a Modulator of Autophagy: An Hypothesis
González-Polo, R., Niso-Santano, M., Gómez-Sánchez, R., Pedro, J. M. B.-S., & Fuentes, J. M. (2010) · TheScientificWorldJournal · doi:10.1100/tsw.2010.165 · Cited by 5
The Lysosome in Aging‐Related Neurodegenerative Diseases
Nixon, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch9 · Cited by 5
Neuronal Autophagy Failure Drives α-Synuclein Transfer to Microglia to Outsource Aggregate ClearancePreprint
Chakraborty, R., Samella, P., Testa, V., Montero-Muñoz, J., Nonaka, T., Hasegawa, M., Consiglio, A., & Zurzolo, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.19.590207 · Cited by 5
Mechanistic insights of molecular chaperone Hsp70: Pathogenesis of neurodegenerative diseases
Choudhary, A., Kumar, P., Jagtap, Y. A., Kinger, S., Jha, H. C., Gutti, R. K., Sharma, V., Prajapati, V. K., & Mishra, A. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2025.05.001 · Cited by 5
Role of LRRK2 in axonal transport and Parkinson’s disease
Twellsieck, B., & Boecker, C. A. (2025) · Biochemical Journal · doi:10.1042/bcj20253133 · Cited by 7
Recombinant cathepsins B and L promote α-synuclein clearance and restore lysosomal function in human and murine models with α-synuclein pathology
Balta, D., Varghese, A., Huarcaya, S. P., Spiezio, A. D., Marques, A. R. A., Akdaş, E. Y., Tabakacilar, D., Drobny, A., Werner, C. D., Xiang, W., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00886-1 · Cited by 4
Genetic modifiers of synucleinopathies—lessons from experimental models
Lee, R. M. Q., & Koh, T. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvad001 · Cited by 4
The αSynuclein half-life conundrum
Masato, A., & Bubacco, L. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106524 · Cited by 4
Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders
Aziz, O., Bürli, R. W., Fischer, D. F., Frearson, J. A., & Wall, M. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50004-0 · Cited by 5
Autophagic Flux Failure in Neurodegeneration: Identifying the Defect and Compensating Flux Offset
Ntsapi, C., Swart, C., Lumkwana, D., & Loos, B. (2016) · InTech eBooks · doi:10.5772/64197 · Cited by 4
A novel lncRNA FAM151B-DT regulates degradation of aggregation prone proteins
Renganathan, A., Minaya, M. A., Broder, M., Alfradique-Dunham, I., Miller, R. L., Dhavale, D. D., Moritz, M., Bhagat, R., Marsh, J. A., Verbeck, A. C., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03277-6 · Cited by 4
PRKN/parkin-mediated control of SNCA (synuclein alpha) and chaperone-mediated autophagy are defective in cellular, mice models and Parkinson disease-affected brains
dos Santos, L. R., Duplan, E., Debord, J., Fremont, G., Minniti, J., Lauritzen, I., Mutez, E., Leghay, C., Chartier‐Harlin, M., Checler, F., et al. (2026) · Autophagy · doi:10.1080/15548627.2026.2669458 · Cited by 3
The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson’s disease
Shimizu, T., Isik, S., Kamath, N., & Yue, Z. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00555-3 · Cited by 3
Degradation of Misfolded Proteins in Neurodegenerative Diseases: Therapeutic Targets and Strategies
Rajak, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_17 · Cited by 3
Targeting chaperone-mediated autophagy to regulate osteoclast activity as a therapeutic strategy for osteoporosis
Zhang, Y., Li, Q., Peng, X., Ji, P., Zhang, Y., Jin, J., Yuan, Z., Jiang, J., Tian, G., Cai, M., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102311 · Cited by 4
Are Lysosomes Potential Therapeutic Targets for Parkinson’s Disease?
Petese, A., Cesaroni, V., Cerri, S., & Blandini, F. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210809123630 · Cited by 3
Significant Role of Long Non-coding RNAs in Parkinson’s Disease
Chen, N., Wen-Wen, C., Li, W., Zhou, A.-J., & Wang, T. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220922110551 · Cited by 3
Emerging autophagic endo-lysosomal targets in the management of Parkinson's disease
Siddiqui, T., & Bhatt, L. K. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.07.007 · Cited by 2
Protein Quality Control in Neurodegeneration and Neuroprotection
Akhter, Y., Nabi, J., Hamid, H., Tabassum, N., Pottoo, F. H., & Sharma, A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch001 · Cited by 3
Molecular Mechanisms Underlying the Role of Autophagy in Neurodegenerative Diseases
Ahmad, S. T., & Lee, J.-A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-405530-8.00003-0 · Cited by 3
Chaperone‐Mediated Autophagy and Parkinson's Disease
Martínez‐Vicente, M., & Wong, E. (2011) · Wiley eBooks · doi:10.1002/9781118063903.ch3 · Cited by 3
Identifying Targets in α‐Synuclein Metabolism to Treat Parkinson Disease and Related Disorders
Tomlinson, J. J., Cullen, V., & Schlossmacher, M. G. (2010) · doi:10.1002/9780470572702.ch37 · Cited by 3
Age-related pathological impairments in induced neurons derived from patients with idiopathic Parkinson’s diseasePreprint
Drouin‐Ouellet, J., Pircs, K., Legault, E. M., Birtele, M., Nilsson, F., Shrigley, S., Pereira, M., Storm, P., Sharma, Y., Vuono, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.441070 · Cited by 3
Chaperone‐Mediated Autophagy: A Critical Regulator of Neuroinflammation and Neurodegeneration
Han, Y., Huang, X., Su, Y., Ma, J., & Wu, J. (2025) · Advanced Biology · doi:10.1002/adbi.202500191 · Cited by 3
Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and parkinsonian motor deficits
Sanchiz-Calvo, M., Coccia, E., Cawthorne, C., Parfitt, G. M., Torre-Muruzabal, T., Tsafaras, G., Laere, K. V., Cabezudo, D., Cascalho, A. C. C., den Haute, C. V., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02908-0 · Cited by 2
Lysosomal Network Defects in Early-Onset Parkinson’s Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes
Pascual, A., Moulka, T., de Fàbregues, O., Repossi, R., Ruiz, P., Ortolano, S., Lucca, M. D., Vela, L., Alves-Villar, M., Frías, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199454 · Cited by 2
Modulation of Bromo- and Extra-Terminal Domain (BET) Proteins Exerts Neuroprotective Effects in Cell Culture Models of Parkinson’s Disease
Martella, N., Pensabene, D., Colardo, M., Muzzi, M., Bisesto, E., Varone, M., Caretti, G., Porzio, A. D., Barrella, V., Mazzoli, A., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14010244 · Cited by 2
Autophagy–exosome crosstalk in neurodegeneration: Mechanisms and therapeutic opportunities
Sedighi, S., Guan, T., Michetti, F., Cordani, M., Behrooz, A. B., Sabouni, F., Eshraghi, M., Saleem, A., Ghavami, S., & Aghanoori, M. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109025 · Cited by 3
The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson’s Disease Pathogenesis
Sain, M., Rani, S., Singh, S., Pothal, P., Yadav, S., Suttee, A., Kumar, A., Kumar, S., Ranawat, P., Singh, G., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05917-6 · Cited by 2
Blm10/ PA200 ‐Activated 20S Proteasomes Promote α‐Synuclein Degradation and Bypass Proteasome Inhibition in Parkinson's Disease Models
Ali, T. T., Zhornyak, A., Merghani, M. M., Buschenlange, Z., Sakata, E., Outeiro, T. F., Popova, B., & Braus, G. H. (2026) · Aging Cell · doi:10.1111/acel.70566 · Cited by 2
Protein clearance mechanisms and their demise in age-related neurodegenerative diseases
Sáez, I., & Vı́lchez, D. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.1.1 · Cited by 2
Interferon‐β may ameliorate synucleinopathy
Fuseya, Y., & Takahashi, R. (2016) · Movement Disorders · doi:10.1002/mds.26570 · Cited by 2
Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model
Cuevas, E., Guzmán, A., Burks, S. M., Ramirez-Lee, A., Ali, S. F., & Imam, S. Z. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.03.047 · Cited by 2
Autophagy and Parkinson’s Disease
Ryan, L., Rob, M., He, J., & Rubinsztein, D. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_242 · Cited by 2
Autophagy markers, cognitive deficits and depressive symptoms in Parkinson’s disease
Li, Y., Yang, H., Zhao, P., Yang, J., Yao, C., Zhou, C., Yang, C., Sun, X., Li, S., & Li, J. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02702-w · Cited by 2
Involvement of Autophagic Machinery in Neuropathogenesis: Targeting and Relevant Methods of Detection
Sayed, N., Ali, A. E., Elsherbiny, D. A., & Azab, S. S. (2024) · Methods in molecular biology · doi:10.1007/7651_2024_516 · Cited by 2
Overview of Autophagy
Hayat, M. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805420-8.00001-9 · Cited by 3
Gene Expression of Lysosomal Membrane Proteins in Parkinson Disease, Associated with Mutations in the Glucocerebrosidase Gene (GBA)
Usenko, T. S., Bezrukova, A. I., Bogdanova, D., Nikolaev, M. A., Miliukhina, I. V., Gracheva, E., Senkevich, K. A., Zakharova, E. Y., Emelyanov, A., & Pchelina, S. (2020) · Annals of Clinical and Experimental Neurology · doi:10.25692/acen.2020.2.6 · Cited by 2
Altered autophagy on the path to Parkinson's disease
Sanchez-Mirasierra, I., Hernández-Díaz, S., Ghimire, S., Main, P., & Soukup, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822003-0.00006-1 · Cited by 2
Autophagy and Protein Quality Control in Parkinson's DiseasePreprint
Martínez‐Vicente, M., & Vila, M. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041619 · Cited by 2
Astrocytes and the Synucleinopathies
Koob, A. O., & Sacchetti, P. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_8 · Cited by 1
Autophagy Mechanisms for Brain Recovery. Keep It Clean, Keep It Alive
Nobili, A., Barbera, L. L., Mastrantonio, R., Palazzo, C., Molinari, M., D’Amelio, M., & Viscomi, M. T. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24930-3_2 · Cited by 1
Hytrin Nanoformulation Reduces Nitrated Synucleinopathy Through Chaperon-Mediated Autophagy
Sardoiwala, M. N., Boddu, M., Biswal, L., Karmakar, S., & Choudhury, S. R. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c00137 · Cited by 1
KFERQ-selective protein autophagy in Caenorhabditis elegans depends on LMP-1
Gallardo-Campos, M., Minniti, A. N., Hormazábal, J., Núñez, G., Lagos, C. F., Pérez‐Acle, T., Aldunate, R., & Alfaro, I. E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0330339 · Cited by 1
Toxic Tango in Parkinson's Disease: A dance between αSyn and iron import, export and speciation
Cosson, T., Faller, P., & Pountney, D. L. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106053 · Cited by 1
C-terminus-dependent detection of lysosomal alpha-synuclein in nigral Parkinson’s disease human brain neurons
Morella, M. L., Khayrat, B. A., Moors, T. E., Veld, L. I. ‘., Frigerio, I., Udayar, V., van der Gaag, B., & van de Berg, W. D. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00884-3 · Cited by 2
Familial mutations modulate α‐synuclein interactions with key neuronal membrane lipids
Ali, A., Matveyenka, M., & Kurouski, D. (2025) · FEBS Journal · doi:10.1111/febs.70363 · Cited by 1
Exercise suppresses apoptosis for alleviating Parkinson’s disease: effects on pathophysiological molecular pathways
Chen, J., Liu, X., Wu, Y., Wang, C., & Wang, C. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1810397 · Cited by 1
Research progress on the α-synuclein-lysosome axis in Parkinson’s disease: molecular mechanisms of protein aggregation, autophagy dysfunction, and therapeutic targeting
Fu, J., Zhu, C., & Fan, Z. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1885103 · Cited by 1
Lysosomal dysfunction in neurodegenerative disease
Brooker, S. M., Coukos, R., & Krainc, D. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01262-3 · Cited by 1
Role of Chaperone-Mediated Autophagy in Ageing and Neurodegeneration
Ferreira, J. V., Pereira, P., & Girão, H. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_2 · Cited by 1
Control of Autophagy in Parkinson’s Disease
González‐Polo, R. A., Gómez‐Sánchez, R., Pizarro‐Estrella, E., Yakhine-Diop, S. M. S., Rodríguez‐Arribas, M., & Fuentes, J. M. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_6 · Cited by 1
Autophagosomes and multivesicular bodies in neuronal development and degeneration
Diana, A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0048-3 · Cited by 1
AUTOPHAGY IN HUNTINGTON’S AND PARKINSON’S DISEASES: PATHOGENIC MECHANISMS AND THERAPEUTIC POTENTIALS
Lim, J., Friedman, L. G., McKnight, N. C., & Yue, Z. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814350457_0011 · Cited by 1
Oxidative Stress and Neurodegeneration
Pasquini, J. M., Pasquini, L. A., & Quintá, H. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-45865-6_20 · Cited by 1
Autophagy
Lewis, P. A., Pérez‐Carrión, M. D., & Piccoli, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00006-7 · Cited by 2
Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
Datta, I., Raj, A., & Kaushal, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_10 · Cited by 2
Phytochemicals in synucleinopathies: targeting mitochondrial dysfunction and α-synuclein toxicity
Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2023) · Studies in natural products chemistry · doi:10.1016/b978-0-323-91253-2.00011-x · Cited by 1
Knockout of the LRRK2-counteracting RAB phosphatase PPM1H disrupts axonal autophagy and exacerbates alpha-synuclein aggregation
Fricke, M., Mechel, A., Evers, L., Twellsieck, B., Grein, J. M., Cima‐Omori, M., Al‐Azzani, M., Outeiro, T. F., Zweckstetter, M., Holzbaur, E. L. F., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117364 · Cited by 2
Cyclin-Dependent Kinase 5 – An Emerging Player in Parkinson’s Disease Pathophysiology
Zelda, H., & Nancy, Y. (2012) · InTech eBooks · doi:10.5772/19153 · Cited by 1
Neurodegeneration models in Drosophila
Roy, B., & Jackson, G. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920585.012 · Cited by 1

Authors: Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L.
Affiliations: Biomedical Research Foundation of the Academy of Athens (GR)
National and Kapodistrian University of Athens (GR)
Corresponding author: Stefanis, Leonidas
ORCID: Xilouri, Maria
Vekrellis, Kostas
Stefanis, Leonidas
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2008-08
Volume: 283
Issue: 35
Pages: 23542-23556
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m801992200
PMC: PMC2527094
OpenAlex: W2026175550
Cited by: 683
References: 44
Citations by year: 2026: 28 · 2025: 33 · 2024: 43 · 2023: 44 · 2022: 36 · 2021: 48 · 2020: 56 · 2019: 40 · 2018: 34 · 2017: 32 · 2016: 30 · 2015: 33 · 2014: 39 · 2013: 39 · 2012: 41
FWCI: 22.89
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 4445 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Neurological Disorders and Stroke (R21NS055693)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Keywords: alpha-synuclein, chaperone-mediated autophagy, macroautophagy, Parkinson's disease, LAMP2A, lysosomal degradation, post-transcriptional regulation, PC12 cells, SH-SY5Y cells, cortical neurons, midbrain neurons, protein turnover
MeSH terms: Animals, Autophagy, Cerebral Cortex, Humans, Mesencephalon, Neurons, Parkinson Disease, PC12 Cells, Rats, Wistar, Molecular Chaperones, Mice, Rats, alpha-Synuclein, Lysosomal Membrane Proteins, Lysosomal-Associated Membrane Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks